THE USE OF A NON-NUTRITIVE DIET AND URIC ACID MEASUREMENTS TO DETERMINE FOOD RESERVES IN RHODNIUS PROLIXUS STÅHL (HEMIPTERA: REDUVIIDAE)

1966 ◽  
Vol 44 (1) ◽  
pp. 39-46 ◽  
Author(s):  
F. M. Barrett ◽  
W. G. Friend

Fifth-instar nymphs of Rhodnius prolixus were fed on an artificial diet consisting of 6 g of dextran (mol. wt. 60,000–90,000) and 0.1 g ATP in sufficient 0.15 M NaCl to give 100 ml. This diet causes a dilution of the haemolymph which leads to a decrease in the uric acid concentration, from the unfed level of 12.2 mg/100 ml to 7.3 mg/100 ml on the first day, and 5.2 mg/100 ml on the second day after feeding. The total amount of uric acid in the haemolymph remains constant over this period but increases by almost 80% on the third day. In contrast, the concentration and the total amount of uric acid in unfed insects remain constant over all 3 days. The digestive activation observed in insects fed on rabbit blood also occurs in insects fed the artificial diet, although it is delayed for 1 or 2 days in the latter. It has been shown that the "gut residue" in R. prolixus has a nutritive value and that this residue is utilized by the insect during periods of starvation.

2006 ◽  
Vol 34 (01) ◽  
pp. 77-85 ◽  
Author(s):  
Guang-Liang Chen ◽  
Wei Wei ◽  
Shu-Yun Xu

In this study, we investigated the effects and mechanisms of Total Saponin of Dioscorea (TSD) on animal experimental hyperuricemia. Mouse and rat hyperuricemic models were made by orally administering yeast extract paste once a day (30 and 20 g/kg, respectively), for 7 days. Yeast would disturb normal purine metabolism by increasing xanthine oxidase (XOD) activity and generating large quantities of uric acid. This model is similar to human hyperuricemia, which is induced by high-protein diets, due to a purine and nucleic acid metabolic disturbance. Another mouse hyperuricemia model was generated by intraperitoneal injection once with uric acid 250 mg/kg or potassium oxonate 300 mg/kg. Potassium oxonate, a urate oxidase inhibitor, can raise the serum uric acid level by inhibiting the decomposition of uric acid. Likewise, injecting uric acid can also increase serum uric acid concentration. The concentration of uric acid in serum or urine was detected by the phosphotungstic acid method, and the activity of XOD was assayed by a test kit. The results showed that TSD (240, 120 and 60 mg/kg, ig) could significantly lower the level of serum uric acid in hyperuricemic mice. TSD (120 and 60 mg/kg, ig) could also lower the level of serum uric acid in hyperuricemic rats, reduce the activity of XOD in the serum and liver of hyperuricemic rats, and increase the level of urine uric acid concentration as well as 24-hour total uric acid excretion. In conclusion, TSD possesses a potent anti-hyperuricemic effect on hyperuricemic animals, and the mechanism may be relevant in accelerating the excretion and decreasing the production of uric acid.


The Lancet ◽  
2008 ◽  
Vol 372 (9654) ◽  
pp. 1953-1961 ◽  
Author(s):  
Abbas Dehghan ◽  
Anna Köttgen ◽  
Qiong Yang ◽  
Shih-Jen Hwang ◽  
WH Linda Kao ◽  
...  

2017 ◽  
Vol 473 ◽  
pp. 160-165 ◽  
Author(s):  
Cai-Feng Yue ◽  
Pin-Ning Feng ◽  
Zhen-Rong Yao ◽  
Xue-Gao Yu ◽  
Wen-bin Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document